Biora Therapeutics's market cap is currently $542.72K. The company's EPS TTM is $-13.034; its P/E ratio is ―; Biora Therapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-3.50. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 4.00K	$ 305.00K	$ 1.25M	$ 74.31M	$ 143.99M
Gross Profit	$ 4.00K	$ -602.00K	$ -190.00K	$ -19.12M	$ 43.49M
Operating Income	$ -67.14M	$ -61.78M	$ -117.84M	$ -195.19M	$ -140.12M
EBITDA	$ -114.05M	$ -37.35M	$ -164.57M	$ -106.18M	$ -135.44M
Net Income	$ -124.11M	$ -48.83M	$ -178.52M	$ -192.53M	$ -148.04M
Balance Sheet
Cash & Short-Term Investments	$ 15.21M	$ 30.49M	$ 88.40M	$ 92.08M	$ 33.04M
Total Assets	$ 31.21M	$ 53.52M	$ 108.84M	$ 154.44M	$ 101.73M
Total Debt	$ 47.43M	$ 127.81M	$ 126.40M	$ 162.31M	$ 73.37M
Net Debt	$ 32.22M	$ 97.33M	$ 38.01M	$ 70.23M	$ 40.33M
Total Liabilities	$ 132.64M	$ 155.81M	$ 193.81M	$ 261.43M	$ 185.60M
Stockholders' Equity	$ -101.42M	$ -102.29M	$ -84.98M	$ -106.99M	$ -83.87M
Cash Flow
Free Cash Flow	$ -48.60M	$ -65.21M	$ -168.34M	$ -170.69M	$ -109.85M
Operating Cash Flow	$ -48.50M	$ -64.42M	$ -167.49M	$ -165.74M	$ -106.12M
Investing Cash Flow	$ 2.44M	$ -792.00K	$ -1.24M	$ -4.94M	$ 16.52M
Financing Cash Flow	$ 30.78M	$ 7.30M	$ 165.05M	$ 229.72M	$ 73.64M

Currency in USD

Biora Therapeutics Earnings and Revenue History

Income Statement >

Biora Therapeutics Debt to Assets

Balance Sheet >

Biora Therapeutics Cash Flow

Cash Flow >

Biora Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing